Resources & Insights
Meet the PharPoint Team: Meg D., Accounts Receivable Manager, Finance
Get to know PharPoint’s Accounts Receivable Manager, Meg, in this month’s Meet the PharPoint Team feature.
Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs
This brief guide provides timeline benchmarks for Sponsors evaluating biometrics contract research organizations (CROs).
Meet the PharPoint Team: Mital J., Senior Auditor, Quality Assurance
Get to know PharPoint’s Sr. QA Auditor Mital J., in the latest Meet the PharPoint Team series feature.
Developing a Comprehensive Yet Concise DMC Charter
Discover what an effective DMC charter should look like and what contents are required with PharPoint DMC coordinator Victoria.
Clinical Trial Design: Ensuring Statistical Validity and Identifying Consulting Biostatisticians
Why engage a biostatistician early in the study design process, and how do you identify the right consultant for your study?
Meet the PharPoint Team: Shantyana R., Principal Data Manager, Data Management
Principal Data Manager Shantyana R. gives an inside look at her job responsibilities and shares why she believes PharPoint is not your average CRO.
Statistical Support for Regulatory Submissions and Confidently Navigating Regulatory Discussions
How can an experienced biostatistician provide critical support before and during the regulatory submission process?
The Rising Need for Data Monitoring Committee Member Training
Exploring industry perspectives and insight regarding data monitoring committee member training with PharPoint DMC coordinator Victoria Elder.
Key Interactions Between Biometrics Teams for a More Efficient Clinical Trial
Discover key interactions between clinical data management and biostatistics teams for a more efficient clinical trial.
A Review of the 2024 Draft Guidance for DMCs
In early 2024, FDA released an updated draft guidance for data monitoring committees (DMCs).